Management of Incidental Thyroid Nodules in the Pretransplant Population.

Papillary thyroid carcinoma Thyroid incidentaloma Transplant population Workup

Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
08 Oct 2024
Historique:
received: 25 02 2024
revised: 08 08 2024
accepted: 08 09 2024
medline: 10 10 2024
pubmed: 10 10 2024
entrez: 9 10 2024
Statut: aheadofprint

Résumé

The incidence of thyroid nodules has increased as diagnostic imaging has become more prevalent, but the management in transplant candidates, a high-risk population because of the need for chronic immunosuppression, has not been described. We sought to review our institution's approach to thyroid nodules incidentally found during pretransplant workup. A multisite retrospective review was performed of pretransplant patients with incidental thyroid nodules diagnosed between 2011 and 2021. Demographics, nodule characteristics, treatment timeline, and oncologic outcomes were collected. Patients diagnosed before and after 2017 were compared to evaluate how adoption of Thyroid Imaging Reporting and Data System and expansion of a dedicated transplant center were correlated with changes in patient management. A total of 10,340 patients underwent abdominal transplant, 236 had incidental thyroid nodules. After 2017, radiology recommendations for biopsy decreased from 39% to 29% (P = 0.174) and fewer biopsies were performed, 45%-33% (P = 0.055). Time between imaging and biopsy was significantly shorter after 2017, from 14 mo to 4 (P = 0.038). Overall time from imaging to transplant was also significantly reduced, from 31 mo to 11 (P < 0.001). Thirty-one (13.1%) patients underwent thyroid surgery before transplant and four (1.7%) patients after. In the recent years, thyroid biopsy rates for thyroid incidentalomas found during pretransplant workup have decreased and more closely match imaging-based guideline recommendations. Patients who required biopsy obtained them sooner and underwent transplant surgery sooner. Guideline-driven thyroid incidentaloma workup for the pretransplant population allows for timely and appropriate cancer care while avoiding unnecessary delays in transplant.

Identifiants

pubmed: 39383598
pii: S0022-4804(24)00565-1
doi: 10.1016/j.jss.2024.09.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

248-253

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Patricia G Lu (PG)

Mayo Clinic Arizona, Department of Surgical Oncology and Endocrine Surgery, Phoenix, Arizona. Electronic address: Lu.patricia@mayo.edu.

Patrick T Hangge (PT)

Mayo Clinic Arizona, Department of Surgical Oncology and Endocrine Surgery, Phoenix, Arizona.

Amit K Mathur (AK)

Mayo Clinic Arizona, Department of Transplant Surgery, Phoenix, Arizona.

Nabil Wasif (N)

Mayo Clinic Arizona, Department of Surgical Oncology and Endocrine Surgery, Phoenix, Arizona.

Zhi Ven Fong (Z)

Mayo Clinic Arizona, Department of Surgical Oncology and Endocrine Surgery, Phoenix, Arizona.

Patricia A Cronin (PA)

Mayo Clinic Arizona, Department of Surgical Oncology and Endocrine Surgery, Phoenix, Arizona.

Cameron Adler (C)

Mayo Clinic Arizona, Department of Radiology, Phoenix, Arizona.

Frederick Chen (F)

Mayo Clinic Arizona, Department of Radiology, Phoenix, Arizona.

Chee-Chee H Stucky (CH)

Mayo Clinic Arizona, Department of Surgical Oncology and Endocrine Surgery, Phoenix, Arizona.

Classifications MeSH